Hong Kong Scientists Say Plasma From H1N1 Patients Treats New Ones
This article was originally published in PharmAsia News
Executive SummaryHong Kong researchers said they have discovered that plasma from recovered and convalescing patients could be used to treat newer patients with severe cases of the H1N1 flu virus. The Hong Kong University scientists said the plasma contains hyperimmune intravenous immunoglobulin that proved useful in tests for treating the viral infection. They noted the low mortality of the current flu in Hong Kong is occurring during a wet season, but said the virus could be quite different during the winter when the weather is dry, leading to a higher mortality rate. (Click here for more
You may also be interested in...
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.
Keeping Track Of Thanksgiving Leftovers: Risdiplam, Artesunate Highlight Glut Of Submissions/Filings
Yes, we know they should be out of the fridge by now, but here are the highlights of submissions and filings during the Thanksgiving week.
HBW Executive Decisions: HELP Endorses Hahn, Industry Award For AHPA's McGuffin, CHPA, Herbalife Hires
CHPA adds Allgaier to head development, relations; Vetere joins Herbalife as VP, CIO; Hahn's FDA commissioner nomination clears HELP committee; and AHPA's McGuffin recognized as 2019 Industry Leader.